TE_38967
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | HERVK3 |
|---|---|
| TE superfamily | ERV2 |
| TE class | LTR |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 2.25 |
| Counts of samples | TCGA_tumor:1; TCGA_normal:0; GTEx:0 |
| TSS | chrY(-):17942336 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_38967.1 | - | Intergenic | Non-coding | Non-coding | chrY(-):17910968,17910988,17941991,17942337 |
| teRNA_38967.2 | - | Intergenic | Non-coding | Non-coding | chrY(-):17941416,17941436,17941991,17942337 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
